Cardiovascular risk factors play greater role in adverse outcomes in thymic cancer patients
Thymic cancer, a rare type of cancer that has brought patients to Indiana University Health in recent years for treatment, has become the subject of further study between investigators from the Krannert Cardiovascular Research Center and the Melvin and Bren Simon Comprehensive Cancer Center at Indiana University School of Medicine, and collaborators at Regenstrief Institute. The researchers wanted to explore cardiovascular risk factors for adverse outcomes among people with and without thymic cancer. Results of their study was published in Frontiers.
Dr. Marino, others demonstrate the importance of studying the “normal breast”
Natascia Marino, PhD, assistant research professor of medicine at IU School of Medicine and a research scientist with the Komen Tissue Bank at the IU
Genomic medicine key to treating aggressive breast cancers disproportionately affecting African American women
Compared to white women, the lifetime risk of developing breast cancer is slightly lower for African Americans; however, the risk of dying from the disease
Clinical Trials Office juggles research work, life amid a pandemic
Before the World Health Organization declared the spreading coronavirus outbreak a pandemic on March 11, the staff of the IU Simon Comprehensive Cancer Center’s Clinical Trials
2 students with interest in combining cancer research with patient care are Wright Scholarship recipients
Two women pursuing their medical degrees with an interest in combining cancer research with patient care have been selected as the 2020 IU Simon Comprehensive Cancer
IU physicians, Purdue scientists collaborate to develop a test to detect kidney cancer
Cancer physicians at Indiana University and scientists at Purdue University are working to develop a urine test that would enable patients to avoid an invasive,
Named an IU Distinguished Professor, Roodman continues storied multiple myeloma research career
Progress in multiple myeloma research and improved outcomes for patients is the driving force for physician scientist G. David Roodman, M.D., Ph.D. Roodman started researching
Trio tackles leukemia
Whether finding new targets or discovering better therapies, three investigators are working to tackle the most common type of pediatric cancer.
Top 10 recipients of NIH funding for federal fiscal year 2019
Liana Apostolova, MD, MSc, FAAN, and Apoorva Sanjay Bharthur At Indiana University School of Medicine, the 2019 fiscal year set another record for NIH-funded research,